Forty subjects with schizophrenia and 40 age- and sex-matched controls
were recruited, and blood samples were obtained for analysis of red c
ell membrane fatty acid composition by capillary gas chromatography. A
blood sample was also taken from the same population to test for alle
lic association between schizophrenia and a polymorphism close to the
promoter site of the cytosolic phospholipase-A2 gene which is mapped t
o chromosome 1q25. The schizophrenic population was heterogeneous with
regards age,symptom severity and treatment. A significantly higher pe
rcentage concentration of dihomogamma-linolenic acid (DGLA) was found
in the red cell membranes of schizophrenics compared to matched contro
ls. All other fatty acids examined showed no difference from the norma
l population. No correlation was found between any demographic factor,
treatment variable, diet, drug use, alcohol or tobacco consumption wh
ich could explain the biochemical findings. A negative correlation was
found between the concentration of DGLA in red blood cell (RBC) membr
anes and severity of symptoms of schizophrenia. In particular, there w
as a significant correlation (r = - 0.41, p = 0.009) between DGLA perc
entage concentrations and 'disorganised' symptoms. No association was
found between schizophrenia and alleles of the polymorphism near the p
hospholipase-A2 gene or between fatty acid concentrations and the pres
ence of any particular alleles. This study therefore finds support for
membrane phospholipid abnormalities in patients with schizophrenia an
d particular symptom clusters, but does not replicate a previous repor
t of an allelic association between a polymorphism close to the site o
f the cytosolic phospholipase-A2 gene and schizophrenia. (C) 1998 Else
vier Science B.V. All rights reserved.